Skip to main content
Clinical Trials/NCT01572233
NCT01572233
Unknown
N/A

Effects of Personalized Physical Activity and Psycho-Education Program on Patients With Chronic Hepatitis C Infection

National Taiwan University Hospital1 site in 1 country300 target enrollmentDecember 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hepatitis C Virus Infection, Response to Therapy of
Sponsor
National Taiwan University Hospital
Enrollment
300
Locations
1
Primary Endpoint
Effects of Activity and Education Program on Patients with Chronic Hepatitis C Infection
Last Updated
13 years ago

Overview

Brief Summary

This 4-year project will be guided by a biobehavioral model for the study of exercise interventions in two phases with the purposes to :

  1. explore the patients' physical activity preferences and develop doable activity lists during treatment period
  2. examine the changes of health-related physical fitness component over interferon treatment
  3. develop the Personalized Physical Activity and Psych-Education (PPAPE) Program and test its effects on decreasing fatigue, physical and psychological distress, and improving their health-related physical fitness and quality of life in patients with chronic hepatitis C receiving Interferon with Ribavirin Combination Therapy
  4. evaluate the outcome of the PPAPE program on increasing adherence to therapy, the sustained virological response (SVR) in 24 weeks after the end of treatment, and the time-consuming for education program during intervention.
Registry
clinicaltrials.gov
Start Date
December 2011
End Date
June 2018
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with Chronic Hepatitis C Infection Receiving Interferon Therapy
  • Aged above 18

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Effects of Activity and Education Program on Patients with Chronic Hepatitis C Infection

Time Frame: 4-year project

Phase I of this project, the first and second year, the measurement time will be collected on the baseline (before treatment, T0), the 8 weeks (T1), 16 weeks (T2), and 24 weeks (T3) during treatment.

Study Sites (1)

Loading locations...

Similar Trials